Liver p53 expression in patients with HCV-related chronic hepatitis

J Viral Hepat. 2003 Jul;10(4):266-70. doi: 10.1046/j.1365-2893.2003.00432.x.

Abstract

Mutated p53 acts as a dominant oncogene and alterations in the p53 gene are described in a large number of patients with hepatocellular carcinoma (HCC). It has been demonstrated that hepatitis C virus (HCV)-core protein regulates transcriptionally cellular genes, as well as cell growth and apoptosis. This study was undertaken to evaluate whether p53 may be expressed also in a precocious stage of HCV-related liver damage. We studied p53 expression by immunoluminometric assay on liver samples from 40 patients (M/F 18/ 22, median age 44 years, range 13-64 years) with biopsy-proven HCV-related chronic hepatitis. We considered the following factors: degree of liver damage, liver iron content and HCV-RNA titre. We also evaluated as possible co-factors alcohol and food intake in the last 3 years. p53 was over-expressed in seven of 40 (17.5%) patients. Liver histology documented the presence of unexpected cirrhosis in two patients among the p53 positive subjects. The p53 positive group had a daily ethanol intake significantly higher in respect to that of the p53 negative group (P < 0.05). Alimentary history documented that patients with a p53 over-expression had a lower intake of total calories, monounsaturated fatty acids, vitamin C and riboflavin. Data indicate that p53 over-expression can occur even in initial stages of HCV-related liver disease.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Analysis of Variance
  • Biopsy, Needle
  • Case-Control Studies
  • Chi-Square Distribution
  • Cohort Studies
  • DNA, Viral / analysis
  • Female
  • Gene Expression Regulation, Viral
  • Genetic Predisposition to Disease*
  • Hepacivirus / genetics*
  • Hepatitis C, Chronic / genetics*
  • Hepatitis C, Chronic / pathology*
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Probability
  • Proto-Oncogene Proteins / genetics
  • Reference Values
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sensitivity and Specificity
  • Statistics, Nonparametric
  • Tumor Suppressor Protein p53 / genetics*

Substances

  • DNA, Viral
  • Proto-Oncogene Proteins
  • Tumor Suppressor Protein p53